http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113975593-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84cf48c9f2f0209b37e5493aef196e39
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-602
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-1031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-105
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-1027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-1029
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L29-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L29-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L29-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-10
filingDate 2021-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e82676aa6842f1757420de190b4789e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b200de1afb99e518bfa18b9781da29a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1caad8fee3423d03f3491422f21fafb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7343bcf253b9355368dff0280be73dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbde5ec7edda33219ee791f0a77b5b55
publicationDate 2022-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113975593-A
titleOfInvention Kedalong medicine balloon and preparation method thereof
abstract The invention relates to a medicine balloon of a codantone and a preparation method thereof, which is obtained by coating a mixed solution of the codantone, polyglycolide and polycaprolactone on the surface of the balloon. Compared with the drug treatment, the invention has the advantages of reduced drug dosage, no drug withdrawal rate and greatly reduced side effect; compared with non-drug treatment, the invention has mature application technology, does not need to damage normal cardiac muscle and has less clinical complications; compared with the medicine for use in the pericardium, the invention does not need a special catheter, has low technical operation difficulty and strong operability; the treatment costs required for the present invention are minimal compared to other treatment methods.
priorityDate 2021-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533141

Total number of triples: 31.